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ABSTRACT Free fatty acid induction of inflammation and cell death is an important feature 
of nonalcoholic steatohepatitis (NASH) and has been associated with disruption of the endo-
plasmic reticulum and activation of the unfolded protein response (UPR). After chronic UPR 
activation, the transcription factor CHOP (GADD153/DDIT3) triggers cell death; however, the 
mechanisms linking the UPR or CHOP to hepatoceullular injury and inflammation in the 
pathogenesis of NASH are not well understood. Using HepG2 and primary human hepato-
cytes, we found that CHOP induces cell death and inflammatory responses after saturated 
free fatty acid exposure by activating NF-κB through a pathway involving IRAK2 expression, 
resulting in secretion of cytokines IL-8 and TNFα directly from hepatocytes. TNFα facilitates 
hepatocyte death upon exposure to saturated free fatty acids, and secretion of both IL-8 and 
TNFα contribute to inflammation. Of interest, CHOP/NF-κB signaling is not conserved in 
primary rodent hepatocytes. Our studies suggest that CHOP plays a vital role in the patho-
physiology of NASH by induction of secreted factors that trigger inflammation and hepato-
cellular death via a signaling pathway specific to human hepatocytes.
INTRODUCTION
Nonalcoholic fatty liver disease includes a range of pathologies 
from simple hepatic steatosis to nonalcoholic steatohepatitis 
(NASH), which is characterized by hepatic inflammation and injury 
that can progress to cirrhosis (Masuoka and Chalasani, 2013; 
Berlanga et al., 2014). Insulin resistance is a risk factor for NASH, 
contributing to excessive lipolysis within adipose tissues that 
liberates free fatty acids (FFAs) from triglycerides. Elevated serum 
FFAs have a key role in the pathogenesis of NASH, and therapies 
that enhance insulin sensitivity ameliorate hepatic lipotoxicity, in 
part, by decreasing plasma FFAs. Saturated FFAs are more strongly 
implicated in hepatic lipotoxicity and are more potent inducers of 
hepatocyte death than unsaturated FFAs (Ricchi et al., 2009; Fu 
et al., 2012; Berlanga et al., 2014). Like other liver pathologies, in-
flammation due to cytokine activation and release of alarmins from 
stressed and dying cells are considered to be central to disease 
progression, but the pathways linking FFA lipotoxicity and inflam-
mation in the progression of NASH are not yet well understood 
(Brenner et al., 2013).
Recent studies suggest that saturated FFAs disrupt endoplasmic 
reticulum (ER) function, inducing the unfolded protein response 
(UPR), which features transcriptional and translational expression of 
genes that serve to restore cell homeostasis (Malhi and Kaufman, 
2011; Fu et al., 2012). The UPR is activated through sensory proteins 
IRE1 and PKR-like endoplasmic reticulum kinase (PERK/EIF2AK3), 
each of which is associated with the ER and senses perturbations in 
this organelle (Walter and Ron, 2011). IRE1 is an endoribonuclease 
that facilitates cytosolic splicing of XBP1 mRNA, leading to synthesis 
of an active XBP1s transcription factor, which induces expression of 
UPR genes. PERK phosphorylates the α subunit of eIF2 to repress 
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we stained HepG2 cells with LipidTox. Both saturated and unsatu-
rated FFAs resulted in significant neutral lipid accumulation in 
HepG2 cells; however, the morphology was dissimilar (Figure 1E). 
Palmitate and stearate resulted in diffuse cytoplasmic lipid staining, 
whereas cells treated with oleate formed polarized neutral lipid 
droplets without demonstrable toxicity. These results suggest that 
despite neutral lipid accumulation within cells, the inability of 
HepG2 cells to properly store neutral lipid upon exposure to satu-
rated FFAs is correlated with lipotoxicity, an idea supported by an 
earlier study (Listenberger et al., 2003).
To determine whether the UPR is activated before saturated FFA-
induced cell death, we measured markers of the UPR during a time 
course of exposure to physiological concentrations of free fatty ac-
ids (600 μM; Belfort et al., 2006; Koutsari and Jensen, 2006). Cell 
death first occurred from 12 to 24 h after treatment with either pal-
mitate or stearate (Figure 1, F and G), which was preceded by activa-
tion of the UPR, with increased eIF2α∼P and ATF4 expression after 
just 3 h of saturated FFA exposure and robust expression of CHOP 
at 12 h (Figure 1, I and J). Phosphorylation of PERK at Thr-980, a 
measure of its activation during ER stress, initiated at between 3 and 
6 h of saturated FFA exposure and continued thereafter through the 
24-h time course of treatment (Figure 1, I and J). By comparison, 
oleate had a minimal effect on the UPR, with a modest, transient 
induction of eIF2α∼P and ATF4 levels, minimal phosphorylated 
PERK and CHOP expression, and full cell viability (Figure 1, H and J). 
These findings suggest that oleate treatment leads to only modest 
stress of HepG2 cells, which is rapidly resolved. By comparison, 
saturated FFAs such as palmitate and stearate lead to robust and 
sustained ER stress and induction of the UPR. As a control, we also 
measured activation of the PERK pathway in response to tunicamy-
cin, a well-characterized inducer of ER stress and the UPR. Tunicamy-
cin activated the UPR in a manner similar to saturated FFAs but with-
out any adverse effect on cell viability (Figure 1I and Supplemental 
Figure S1A). This finding suggests that sustained induction of the 
UPR per se is not sufficient to trigger hepatocyte death but instead 
that this is a property triggered by exposure to saturated FFAs.
To confirm further that palmitate indeed activated the UPR as 
opposed to cytosolic stresses that induce eIF2α∼P, we measured 
IRE1-mediated splicing of XBP1 mRNA, as well as GRP78 (BiP) levels 
by quantitative PCR (qPCR). There were significantly elevated 
spliced XBP1 and GRP78 mRNAs upon palmitate treatment of 
HepG2 cells, which were absent during oleate exposure (Figure 1, K 
and L). The timing of the splicing of XBP1 mRNA mirrored that for 
increased CHOP mRNA levels, both of which followed a modest 
increase in ATF4 mRNA levels (Figure 1, M and N). However, there 
was no increase of ATF6 mRNA during treatment with palmitate 
(Supplemental Figure S1B), supporting a previously reported discor-
dant induction of the canonical branches of the UPR (Kitai et al., 
2013). Oleate did induce ATF4 mRNA, consistent with the transient 
induction of this cytoprotective transcription factor (Figure 1N). We 
conclude that saturated FFAs are potent inducers of the UPR in hu-
man hepatocytes before lipotoxicity.
Palmitate disrupts neutral lipid formation by localizing 
directly to the ER
Because both saturated FFAs, but not oleate, induced ER stress along 
with aberrant and diffuse neutral lipid staining preceding cell death, 
we evaluated the ultrastructural features of HepG2 cells treated with 
FFAs. HepG2 cells were treated with vehicle, palmitate, or oleate and 
observed by transmission electron microscopy (Figure 2A). Similar to 
previous neutral lipid staining (Figure 1E), ultrastructural examination 
revealed that oleate treatment produced large neutral lipid droplets 
global translation initiation, decreasing the influx of nascent proteins 
into the ER, thus reducing the load on the ER. In addition, phosphory-
lation of eIF2 (eIF2α∼P) leads to preferential translation of key stress 
response genes via bypass of inhibitory upstream open reading 
frames (uORFs) in the 5′-leader sequences of the targeted mRNAs 
(Baird and Wek, 2012). Preferentially translated genes include ATF4, 
encoding a transcriptional activator that functions to alleviate dam-
age accrued during cellular stress (Walter and Ron, 2011). ATF4 also 
induces transcription of GADD34 (PPP1R15A), involved in feedback 
dephosphorylation of eIF2α∼P, and CHOP (GADD153/DDIT3), a 
transcription factor that can trigger cell death during chronic stress. 
Both GADD34 and CHOP are also subject to preferential translation 
during eIF2α∼P through uORF, which tethers expression of these 
UPR genes to continued ER stress (Baird and Wek, 2012). Prior stud-
ies linked activation of CHOP to cell death, an important pathophysi-
ological feature of NASH and cirrhosis (Marciniak and Ron, 2006; 
Tabas and Ron, 2011). In addition, cytokines from inflammatory cells 
or release of alarmins, also called damage-associated molecular pat-
terns (DAMPs), from injured hepatocytes may contribute to the in-
flammatory responses featured in NASH (Brenner et al., 2013).
How ER stress and CHOP, along with secreted factors, contribute 
to lipotoxicity, liver injury, inflammation, and progression in NASH is 
still unresolved (Malhi and Kaufman, 2011). We hypothesized that 
chronic activation of the UPR and CHOP by excessive saturated 
FFAs links systemic metabolic alterations and hepatotoxicity to the 
progression of NASH. To explore this idea, we used cultured human 
hepatocytes subject to saturated FFAs and showed that CHOP is 
essential for NF-κB activation by a signaling pathway involving 
IRAK2, resulting in secretion of proinflammatory factors, such as tu-
mor necrosis factor-α (TNFα) and interleukin-8 (IL-8), which have dif-
ferential functions in hepatoxicity and inflammation. Although the 
UPR and CHOP are activated in mouse hepatocytes, we found mini-
mal induction of NF-κB, which helps to explain why rodent models 
of NASH fail to fully replicate characteristics of NASH in humans.
RESULTS
Saturated FFAs induce the UPR before lipotoxicity 
in hepatocytes
Rodents are less sensitive to FFA-induced liver injury than humans 
(Larter and Yeh, 2008; Charlton et al., 2011; Takahashi et al., 2012). 
To determine whether this species dependence is a property of he-
patocytes, we measured the sensitivity of human hepatoma HepG2 
cells and primary human, mouse, and rat hepatocytes to 24 h of 
exposure to increasing concentrations of saturated FFA palmitate or 
stearate and unsaturated FFA oleate (Figure 1, A–C). Both saturated 
FFAs triggered significant cell death in HepG2 and primary human 
hepatocytes (LC50 < 600 μM), whereas oleate did not induce cell 
death at concentrations up to 1000 μM (Figure 1D). By contrast, 
mouse and rat primary hepatocytes were less sensitive to palmitate 
and completely resistant to cytotoxic effects of stearate (Figure 1, 
A–D). These results suggest that the species sensitivity to lipotoxic 
effects of saturated FFAs is a property of the hepatocytes.
Because HepG2 cells exhibited similar sensitivity to human pri-
mary hepatocytes after saturated FFA exposure, we used HepG2 
cells to explore further the role of the UPR in hepatocellular stress 
responses to saturated FFAs. As will be discussed later, primary hu-
man hepatocytes also share many of the key features of UPR signal-
ing that we discovered in the HepG2 cells. Hepatic steatosis charac-
terized by intracellular accumulation of neutral lipid in hepatoctyes 
is a quintessential pathophysiologic feature of nonalcoholic fatty 
liver disease (Masuoka and Chalasani, 2013). To determine whether 
HepG2 cells accumulate neutral lipids in response to FFA exposure, 
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FIGURE 1: Saturated but not unsaturated free fatty acids induce the UPR before lipotoxicity in human hepatocytes. 
(A–C) Mouse primary hepatocytes (MPHs), rat primary hepatocytes (RPHs), HepG2 cells, and primary human 
hepatocytes (HPHs) were treated with the indicated concentrations of palmitate, stearate, or oleate for 24 h. Cell death 
was measured by LDH release. (D) LC50 values (micromoles) from LDH release assay were calculated in XLfit using 
four-parameter curve fits. (E) HepG2 cells were stained for neutral lipid accumulation using LipidTox Deep Red imaging 
for up to 24 h. Neutral lipid was quantified by counting total spot counts in PerkinElmer’s Columbus software package 
and normalized to vehicle. (F–H) Cell death was measured by LDH release in HepG2 cells incubated with 600 μM 
palmitate, stearate, or oleate for the indicated times. (I, J) Immunoblot analysis of HepG2 lysates treated with 600 μM 
palmitate, 2 μM tunicamycin, 600 μM stearate, or 600 μM oleate for up to 24 h, as indicated. Measured proteins are 
indicated to the right. (K–N) Changes in gene transcripts from HepG2 cells incubated with 600 μM palmitate or oleate 
for up to 24 h, as indicated. The XBP1s/t is a ratio of the spliced XBP1 mRNA relative to total XBP1 transcript, and the 
measured transcript and length of FFA treatment are also shown.
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Palmitate inhibits initiation of global translation 
in a PERK-dependent manner
Activation of PERK and downstream eIF2α∼P results in a global re-
duction in translation initiation. To address the effects of palmitate 
on translation, we performed polysome profiling using lysates pre-
pared from HepG2 cells treated with vehicle, palmitate, oleate, or 
tunicamycin as a control for ER stress (Figure 2, D–F). Both palmitate 
and tunicamycin reduced large polysomes coincident with accumu-
lation of monosomes, indicative of lowered global translation initia-
tion. Oleate did not alter polysome profiles, consistent with its mini-
mal and transient effects on the UPR. To understand the role of 
PERK during translational repression after palmitate exposure, we 
with a polarized cellular distribution. However, palmitate treatment 
led to crystalline structures in HepG2 cells without the appearance of 
polarized neutral lipid droplets (Figure 2A). Finally, to address the in-
tracellular localization of palmitate, we treated HepG2 cells with 
CLICK-IT palmitic acid, azide. There was significant colocalization of 
the tagged palmitate with ER-associated proteins PERK (27%) and 
calnexin (40%), which were visualized by immunofluorescence (Figure 
2, B and C). These findings indicate that palmitate can localize directly 
to the ER in hepatocytes and that the neutral lipid droplets accumulat-
ing from palmitate have marked differences in character and distribu-
tion relative to neutral lipid accumulation after treatment with the 
nontoxic oleate.
FIGURE 2: Palmitate localizes to the ER and represses global initiation of translation. (A) Electron microscopy showing 
ultrastructures of HepG2 cells treated with vehicle, oleate, or palmitate for the indicated times. (B, C) Spinning disk 
confocal images of CLICK-IT–labeled palmitic acid, azide tagged with Alexa Fluor 488 alklyne, showing colocalization 
with the ER (calnexin) or PERK. The percentage colocalization of palmitate with calnexin and PERK is illustrated to the 
right. (D–F) Polysome profiles of lysates prepared from HepG2 cells treated with vehicle, palmitate, oleate, or 
tunicamycin for 12 h. (G) Polysome profile of PERK KO HepG2 cells treated with either vehicle or palmitate for 12 h. 
(H) Cell death of PERK KO HepG2 cells, as measured by LDH release, treated or not with palmitate. (I) Immunoblot 
analysis of control and PERK KO HepG2 cells after 12-h treatment with vehicle or palmitate.
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Knockdown of CHOP protects hepatocytes from lipotoxicity
Elevated levels of CHOP are suggested to play a role in cell death 
during extended periods of ER stress (Marciniak and Ron, 2006; 
Tabas and Ron, 2011). We addressed the role of CHOP in lipotoxic-
ity by short hairpin RNA (shRNA) knockdown (shCHOP) in HepG2 
cells. Control (shCTRL) and shCHOP cells were then measured for 
cell viability after exposure to palmitate for 24 h. Palmitate treat-
ment led to a modest loss of shCTRL cell viability as measured by 
treated HepG2 cells deleted for PERK by using CRISPR (PERK-KO) 
with palmitate and found that there was no reduction in large poly-
somes relative to vehicle, although there was some accumulation of 
monosomes (Figure 2G). In addition, PERK-KO cells were resistant 
to palmitate-induced lipotoxicity coincident with decreased ATF4 
and CHOP levels (Figure 2, H and I). These results suggest that acti-
vation of PERK due to saturated FFA palmitate is detrimental to 
hepatocyte survival.
FIGURE 3: CHOP induces secretion of factors involved in hepatocyte death. (A) Control (shCTRL) HepG2 cells or those 
knocked down for CHOP (shCHOP #1 and shCHOP #2) were treated with palmitate for 24 h, and cell death was 
measured by LDH release (top). The control and shCHOP cells were incubated for 12 h in the presence (+) or absence 
(–) of 600 μM palmitate, and the indicated proteins were measured by immunoblot (bottom). (B) shCTRL and shCHOP 
HepG2 cells were treated with palmitate for the indicated times, and cell death was measured by LDH release. 
(C) Control (shCTRL) HepG2 cells or those knocked down for ATF4 (shATF4 #1 and shATF4 #2) were treated with 
palmitate for 24 h, and cell death was measured by LDH release (top). Control and shATF4 cells were treated for 12 h in 
the presence (+) or absence (–) of 600 μM palmitate, and the indicated proteins were visualized by immunoblot 
(bottom). (D) Diagram depicting conditioned medium experiment. Donor shCTRL HepG2 cells were incubated with 
600 μM palmitate or control vehicle for up to 24 h, as indicated. The conditioned medium was then transferred to 
recipient shCHOP HepG2 cells for 24 h, and cell death was measured by LDH release. (E) Conditioned medium was 
prepared from shCTRL HepG2 donor cells incubated for 3, 6, 12, or 24 h in the presence of palmitate. Conditioned 
medium was then transferred to recipient shCHOP HepG2, and after a 24-h incubation, cell death was measured by 
LDH release. (F, G) Conditioned medium prepared from donor shCTRL cells cultured with palmitate for 12 or 24 h was 
treated with RNase A, heat inactivation, or proteinase K, and the treated conditioned medium was then incubated with 
recipient shCHOP cells for 24 h. Cell death was measured by LDH release.
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of these factors, we carried out individual sandwich enzyme-linked 
immunosorbent assays (ELISAs) in both control and shCHOP cells 
for IL-8 and TNFα, both of which are increased in patients with 
NASH (Bahcecioglu et al., 2005). There were significant increases in 
the secretion of both IL-8 and TNFα in HepG2 cells treated with 
palmitate, which was sharply lowered in shCHOP cells (Figure 4, B 
and C, and Supplemental Figure S2, A and B). These results indicate 
that CHOP is required for secretion of proinflammatory factors from 
hepatocytes after exposure to saturated FFAs.
Next we sought to address the biological implications of the 
CHOP-dependent secreted factors. We knocked down IL-8 (CXCL8) 
and TNFα (TNFA) in HepG2 cells using shRNA (Figure 4, D and E) 
and found significant reductions in secretion of IL-8 and TNFα 
(Figure 4, F and G). Whereas depletion of IL-8 did not rescue hepa-
tocytes from palmitate-induced cell death relative to control cells 
(Figure 4D), there was a sharp reduction in macrophage migration 
as measured by transwell chemotaxis (Figure 4H). Depletion of 
TNFα both rescued the HepG2 cells from palmitate-induced cell 
death and prevented macrophage migration (Figure 4, E and I). 
These results indicate that CHOP is essential for secretion of factors 
involved in both hepatocyte cell death and proinflammatory signals. 
To address further whether TNFα is a secreted factor by which 
CHOP signaling can drive cell death, we added 12-h conditioned 
medium from palmitate-treated donor control or shTNFA cells to 
recipient shCHOP cells. Whereas conditioned medium from the 
palmitate-treated control cells triggered almost 30% death of recipi-
ent shCHOP cells, conditioned medium from the palmitate-treated 
shTNFA cells caused only ∼5% death (Figure 4J). These results indi-
cate that TNFα is a major CHOP-dependent secreted factor respon-
sible for hepatocyte cell death during exposure to saturated FFAs.
Is TNFα sufficient to trigger death of shCHOP hepatocytes? 
To address this question, we added recombinant TNFα to the 
cultured medium of these cells in the presence or absence of 
palmitate. There was significant death of the shCHOP cells upon 
TNFα treatment only when added in combination with palmitate 
(Figure 4K). By comparison, addition of recombinant IL-8 to the 
shCHOP cells did not have any adverse effect on cell viability. We 
conclude that induced secretion of TNFα is an important reason 
for the CHOP pathway eliciting hepatocyte death upon exposure 
to saturated FFAs. Furthermore, treatment of shCHOP cells with 
the combination of TNFα and IL-8, but neither alone, signaled 
macrophage migration, as judged by transwell chemotaxis 
(Figure 4L). The requirement for both TNFα and IL-8 for the in-
flammatory response is consistent with our finding that knock-
down of either was sufficient to thwart macrophage migration 
(Figure 4, H and I).
CHOP activates NF-κB during palmitate exposure
Transcriptional expressions of CXCL8 (IL-8) and TNFA (TNFα) are 
known targets of NF-κB, so we determined whether CHOP serves 
to activate NF-κB in response to saturated FFAs. Elevated eIF2α∼P 
can reduce synthesis of IκBα, which can contribute to NF-κB activa-
tion (Wek et al., 2006). Indeed IκBα levels were reduced after treat-
ment with the saturated FFAs, which were undeterred in the CHOP-
deficient cells (Figure 5A). In fact, IκBα levels were lowered basally 
in shCHOP cells, contributing to further reductions in IκBα during 
treatment with palmitate. Next we measured phosphorylation of the 
p65 subunit of NF-κB at serine 536, which is suggested to facilitate 
NF-κB targeting to the nucleus and transcriptional activation (Sasaki 
et al., 2005). Phosphorylated p65 was induced in shCTRL HepG2 
cells by palmitate but not in shCHOP cells (Figure 5A). Furthermore, 
phosphorylated p65 localized to the nucleus upon palmitate 
lactate dehydrogenase (LDH) release after 12 h of treatment, with 
∼50% lethality after 24 h of palmitate exposure (Figure 3, A and B). 
By comparison, knockdown of CHOP provided for resistance to 
palmitate, as well as stearate treatment (Supplemental Figure S1C). 
In addition, knockdown of ATF4 (shATF4) in HepG2 cells did not al-
leviate saturated FFA-induced cell death (Figure 3C and Supple-
mental Figure S1D). Of interest, there was still significant induction 
of CHOP protein in the shATF4 cells upon palmitate treatment. 
These findings are consistent with the idea that ATF4 has protective 
functions, whereas elevated CHOP levels facilitate cell death. As 
noted earlier, tunicamycin treatment did not elicit hepatocyte death 
in shCTRL cells, and this cell fate was unaffected by depletion of ei-
ther CHOP or ATF4 (Supplemental Figure S1, C and D).
During liver injury and NASH, release of both autocrine and 
paracrine factors is believed to play a role in disease progression 
(Brenner et al., 2013). We sought to address whether the sensitivity 
of human hepatocytes to saturated FFAs can occur by release of 
paracrine factors. As illustrated in Figure 3D, conditioned medium 
prepared from shCTRL HepG2 cells treated with palmitate for 3, 6, 
12, or 24 h was then applied to recipient shCHOP cells, which were 
incubated for an additional 24 h and assayed for viability. The 12-h 
conditioned medium led to >20% death of the shCHOP cells, with 
∼40% of the cells succumbing to death after incubation with 24-h 
conditioned medium (Figure 3E). By comparison, conditioned me-
dium from donor shCTRL cells treated with oleate or vehicle did not 
have a deleterious effect on survival of the recipient shCHOP cells 
(Supplemental Figure S1E). Furthermore, conditioned medium that 
was prepared from donor shCHOP cells cultured in the presence of 
palmitate did not lead to appreciable cell death of recipient shCHOP 
cells, suggesting an important role for CHOP in the induced secre-
tion of proposed paracrine factor(s) in hepatocyte lipotoxicity (Sup-
plemental Figure S1F). By contrast, conditioned medium prepared 
from donor shATF4 cells led to robust death of recipient shCHOP 
cells (Supplemental Figure S1G), further supporting the idea that 
ATF4 has a primary cytoprotective function and there is sufficient 
CHOP expression to trigger cell death even when ATF4 is depleted. 
Finally, we used another cell survival assay—calcein-AM, a cell-per-
meant dye that measures cell viability—to confirm that there was 
increased death of the shCHOP cells treated with conditioned me-
dium prepared from donor shCTRL cells incubated with palmitate 
for 24 h (Supplemental Figure S1H). By comparison, direct palmitate 
treatment of shCHOP showed robust calcein-AM conversion, con-
sistent with full viability.
To address whether the secreted factor(s) in the conditioned 
medium that triggered death of recipient shCHOP cells are 
polypeptide(s), we treated the 12- and 24-h conditioned media with 
proteinase K or heat inactivation before incubation with the shCHOP 
cells for an additional 24 h (Figure 3, F and I). Both proteinase K and 
heat treatments enhanced survival of the shCHOP cells, whereas 
RNase A treatment had no effect. These results suggest that CHOP 
induces expression and/or subsequent secretion of polypeptide(s) 
released from hepatocytes that can facilitate cell death during expo-
sure to saturated FFAs.
CHOP induces an inflammatory response in hepatocytes 
in response to palmitate
To determine the identity of the secreted factor(s), we profiled the 
conditioned media from Hep2G cells treated with vehicle, palmi-
tate, or oleate by using an inflammatory biomarker screen (Myriad 
RBM). Secretion of several cytokines was induced in hepatocytes 
upon palmitate exposure, including IL-8, IL-7, TNFα, IL-4, and TNF 
receptor 2 (Figure 4A). To address the role of CHOP in the secretion 
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FIGURE 4: CHOP directs hepatocyte secretion of TNFα and IL-8 upon exposure to palmitate. (A) RBM Myriad 
biomarker panel measuring the indicated secreted factors from HepG2 cells treated with either palmitate or oleate for 
12 h. Values are normalized to vehicle treatment, and the number sign (#) indicates that biomarkers were statistically 
significant relative to the oleate treatment group. (B, C) Sandwich ELISAs measuring IL-8 and TNFα from conditioned 
media of shCTRL or shCHOP HepG2 cells treated with 600 μM palmitate or oleate for 12 h or vehicle control. 
(D) Control (shCTRL) HepG2 cells or those knocked down for IL-8 expression (shCXCL8 #1 and shCXCL8 #2) were 
treated with palmitate for 24 h, and cell death was measured by LDH release (top). The indicated proteins were 
measured by immunoblot using lysates prepared from control and shCXCL8 cells incubated for 12 h in the presence (+) 
or absence (–) of 600 μM palmitate (bottom). (E) Control HepG2 and those depleted for TNFα (shTNFA #1 and shTNFA 
#2) were treated with palmitate for 24 h, and cell death was measured by LDH release (top). Immunoblot analyses were 
also carried out to measure the indicated proteins in the shCTRL and shTNFA cells treated with palmitate for 12 h (+) 
or vehicle (–; bottom). (F, G) Sandwich ELISAs for shCXCL8 and shTNFA cells depicting repressed secreted 
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ATF4 did not affect induction of IRAK2 mRNA in response to palmi-
tate (Figure 6B). These results suggest that CHOP, but not ATF4, is 
required for IRAK2 expression after UPR activation by saturated 
FFAs.
To determine the effects of IRAK2 on NF-κB after palmitate ex-
posure, we knocked down IRAK2 in HepG2 with two different shR-
NAs and treated the cells with palmitate (Figure 6C). Depletion of 
IRAK2 significantly lowered phosphorylation of p65 at serine 536 
after palmitate exposure despite elevated CHOP levels, suggesting 
that IRAK2 is a CHOP-dependent protein kinase that helps facilitate 
NF-κB activation in hepatocytes exposed to palmitate. Next we car-
ried out a chemotaxis assay with the KG-1 cells using the condi-
tioned medium from either shCTRL or shIRAK2 cells and deter-
mined that depletion of IRAK2 impaired macrophage migration 
(Figure 6D). Because we previously showed that IL-8 and TNFα are 
both required for macrophage chemotaxis after palmitate treat-
ment, we measured their mRNA levels by qPCR in shCTRL and shI-
RAK2 cells (Figure 6, E and F). There was a sharp reduction in CXL8 
(IL-8) and TNFA (TNFα) transcripts in shIRAK2 cells, consistent with 
lowered NF-κB activity. These results indicate that IRAK2 contrib-
utes to the initiation of an inflammatory response stemming from 
hepatocytes through activation of NF-κB.
To address the role of IRAK2 depletion on hepatocyte lipotoxic-
ity, we evaluated cell death by LDH release in shIRAK2 cells after 
exposure to palmitate. Knockdown of IRAK2 rescued HepG2 cells 
from palmitate-induced cell death (Figure 6G). Furthermore, to ex-
plore whether IRAK2 is required for the secretion of factors involved 
in hepatocyte cell death, we measured the viability of recipient 
shCHOP cells treated with conditioned medium prepared from do-
nor shIRAK2 cells exposed to palmitate (Figure 6H). Knockdown of 
IRAK2 thwarted the ability of the conditioned medium to trigger 
death of the recipient shCHOP cells, supporting the idea that IRAK2 
facilitates NF-κB–directed secretion that can trigger hepatocyte 
death.
CHOP is directly or indirectly required for induction of IRAK2 
mRNA in response to palmitate treatment, as well as for sustained 
IRAK2 protein levels (Figure 6, A–C). However, there was no repro-
ducible increase in the levels of IRAK2 protein in response to satu-
rated FFAs. There was a sharp reduction in global translation in 
HepG2 cells treated with palmitate for 12 h (Figure 2F). Lowered 
global initiation of protein synthesis, as judged by diminished poly-
somes coincident with increased monosomes, was also observed 
after 6 h of treatment with saturated FFAs (Figure 6I). ATF4 and 
CHOP mRNAs are preferentially translated in response to eIF2α∼P, 
which can be visualized by the shift of either transcript from mono-
some to polysome fractions upon palmitate treatment (Figure 6, J 
and K). By contrast, in HepG2 cells treated with palmitate for either 
6 or 12 h, the distribution of IRAK2 mRNA was largely unchanged 
between the monosome and polysome fractions compared with 
nonstressed conditions (Figure 6, L and M). Note that in nonstressed 
treatment (Figure 5B). Finally, transcriptional activity of an NF-κB–re-
sponsive reporter was induced threefold upon treatment of HepG2 
cells with palmitate (Figure 5C). By comparison, shCHOP cells 
showed minimal NF-κB activity. Collectively these results indicate 
that CHOP is required for induced NF-κB transcriptional activation 
in response to saturated FFAs.
We next investigated the requirement for CHOP in activation of 
canonical NF-κB target genes CXCL1, CXCL2, and CXCL3, as well 
as of CXCL8, and TNFA (Figure 5, D–H, and Supplemental Figure 
S2C). For each of these NF-κB-target genes, CHOP depletion 
blocked increased mRNA levels in response to palmitate to the 
same or greater extent as knockdown of RELA, encoding the p65 
subunit of NF-κB. These results suggest that CHOP is not only re-
quired for NF-κB activation of these target genes, but CHOP also 
plays a central role in secretion of proinflammatory cytokines after 
palmitate exposure.
To address whether the decrease in cytokine gene expression in 
shCHOP and shRELA cells affects inflammation, we measured mac-
rophage chemotaxis using 12-h conditioned media from HepG2 
cells treated with palmitate (Figure 5I). Whereas conditioned me-
dium prepared from shCTRL HepG2 cells enhanced migration of 
human KG-1 cells, there was a marked reduction in macrophage 
migration when the conditioned medium was prepared from cells 
depleted for either CHOP or p65. Knockdown of p65 (shRELA) in 
HepG2 cells also prevented cell death after palmitate exposure 
(Figure 5K). However, conditioned media from donor shCTRL 
HepG2 cells triggered death of recipient shCHOP and shRELA cells 
(Figure 5L), supporting the idea that both CHOP and p65 are re-
quired for the activation and secretion of TNFα but are not the 
downstream effector pathway resulting in cell death. These results 
indicate that CHOP is required for the activation of NF-κB–depen-
dent secreted factors that play a role in both cell death and 
inflammation.
CHOP activates NF-κB in part through IRAK2 signaling
CHOP protein is fully induced in shRELA cells in response to palmi-
tate, further supporting the idea that CHOP functions upstream of 
NF-κB (Figure 5J). We proposed that an IRAK protein previously 
linked to NF-κB signaling (Napetschnig and Wu, 2013) may function 
downstream of CHOP in its activation of NF-κB. There are four hu-
man IRAK isoforms—IRAK1, IRAK2, IRAKM, and IRAK4—and we 
measured the mRNA and protein for each in the shCTRL and 
shCHOP HepG2 cells treated with palmitate. IRAK2 mRNA was the 
only isoform induced after exposure to palmitate and was also the 
only isoform for which the mRNA and protein was substantially low-
ered by shCHOP (Figure 6, A and B). Note that the IRAK2 protein 
was not significantly induced in response to palmitate despite the 
robust increase in IRAK2 mRNA. This suggests that CHOP serves to 
enhance IRAK2 mRNA, which is required to maintain IRAK2 protein 
levels during the saturated FFA stress. By contrast, knockdown of 
polypeptides. (H, I) Cell migration assay for KG-1 cells using conditioned medium prepared from shCTRL, shCXCL8, or 
shTNFA cells treated with either vehicle or palmitate for 12 h. (J) Direct treatment indicates cell death of shCHOP cells 
incubated with palmitate for 24 h. Alternatively, donor shCTRL or shTNFA HepG2 cells were incubated with palmitate 
for 12 h. Conditioned medium was then applied to recipient shCHOP cells for 24 h, and cell death was measured by 
LDH release. (K) The shCHOP HepG2 cells were treated with vehicle, 600 μM palmitate, 10 ng/ml TNFα, 1000 ng/ml 
IL-8, or a combination of the recombinant proteins and palmitate for 24 h, as indicated. Cell death was measured by 
LDH release. (L) Conditioned medium was prepared from donor shCHOP HepG2 cells after 12-h treatment with vehicle 
or palmitate, and 10 ng/ml TNFα and/or 1000 ng/ml IL-8 was added to indicated conditioned medium before 
performing the KG1 cell migration assay.
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FIGURE 5: CHOP is required for activation of NF-κB in hepatocytes treated with palmitate. (A) shCTRL or shCHOP 
HepG2 cells were treated with vehicle (–) or palmitate (+) for 12 h, followed by immunoblot analyses that measured the 
indicated proteins. (B) Nuclear localization of total and phospho-p65 was measured by immunofluorescence microscopy 
in HepG2 cells that were treated with palmitate or vehicle. In parallel, Hoescht staining was used to visualize nuclei, and 
the nuclear staining and p65 imaging was merged. (C) An NF-κB reporter plasmid was transiently transfected into 
shCTRL and shCHOP HepG2 cells, which were then treated with vehicle or palmitate for 12 h, and reporter firefly 
luciferase activity was measured and normalized to Renilla luciferase. (D–H) Levels of the indicated gene transcripts 
were measured by qPCR in HepG2 cells that were treated with palmitate for 12 h or vehicle. (I) Cell migration assays 
were carried out for 6 h using KG-1 cells incubated with conditioned medium prepared from HepG2 cells expressing 
shCTRL, shCHOP, or shRELA that were treated with palmitate for 12 h or vehicle. (J) The shCTRL and shRELA HepG2 
cells were treated with vehicle (–) or palmitate (+) for 12 h, and the indicated proteins were measured by immunoblot 
analyses. (K) HepG2 cells expressing shCTRL, shCHOP, or shRELA were cultured in palmitate for 24 h, and cell death 
was measured by LDH release. (L) Conditioned medium was prepared from donor shCTRL cultured in palmitate for 12 h 
and applied to recipient shCTRL, shCHOP, or shRELA HepG2; after a 24-h incubation, cell death was measured by LDH 
release.
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FIGURE 6: CHOP regulates NF-κB through IRAK2 signaling. HepG2 cells expressing shCTRL or shCHOP were cultured 
in the presence (+) or absence (–) of palmitate. (A) The indicated proteins from these cells were then measured by 
immunoblot analyses. (B) Levels of the indicated IRAK isoform mRNAs expressed in these cells were measured by qPCR. 
(C) The shCTRL HepG2 cells or those expressing shIRAK2 were treated with vehicle (–) or palmitate (+) for 12 h, and the 
indicated proteins were measured by immunoblot. (D) Cell migration assay for KG-1 cells using conditioned medium 
prepared from shCTRL or shIRAK2 HepG2 cells that were treated with vehicle or palmitate for 12 h. (E, F) The mRNA 
levels of CXCL8 (IL-8) and TNFA (TNFα) were measured by qPCR in shCTRL and shIRAK2 HepG2 cells treated with 
palmitate for 12 h or vehicle. (G) HepG2 cells expressing shCTRL or shIRAK2 were cultured in the presence of palmitate 
for 24 h, and cell death was measured by LDH release. (H) Direct treatment indicates cell death as measured by LDH 
release of shCHOP cells incubated with palmitate for 24 h. Alternatively, donor shCTRL or shIRAK2 HepG2 cells were 
incubated with palmitate for 12 h. The conditioned medium was then applied to recipient shCHOP cells for 24 h, and 
cell death was measured by LDH release. (I) Polysome profiles of lysates prepared from HepG2 cells treated with 
palmitate or vehicle for 6 h. (J–L) Fractions were collected by the sucrose gradient analyses prepared from the HepG2 
cells treated with palmitate or vehicle for 6 h, and the relative levels of the ATF4, CHOP, and IRAK2 mRNA were then 
determined by qPCR for each fraction. The percentage of the total levels for the indicated gene transcript in each of the 
seven fractions is illustrated. The percentage change in the indicated mRNA association with large polysomes (fractions 
5–7) in response to palmitate is indicated above the polysome. For example, ATF4 showed a 38% increase in transcript 
levels into fractions 5–7 during palmitate treatment. (M) A similar analysis was carried out for changes in IRAK2 mRNA in 
polysome fractions in HepG2 cells treated with palmitate or vehicle for 12 h.
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these results support the model that in human hepatocytes both 
CHOP and NF-κB are activated by palmitate, leading to production 
of TNFα and IL-8, which facilitate cell death and/or inflammatory 
responses.
Because there are significant differences between NF-κB activa-
tion in cell death and inflammation in human primary hepatocytes 
compared with murine hepatocytes, we wanted to determine 
whether secreted factors from human hepatocytes could trigger 
death of mouse hepatocytes. Conditioned medium was prepared 
from donor shCTRL HepG2 cells treated with either vehicle or pal-
mitate and applied to recipient mouse primary hepatocytes (Figure 
7F). There was only a modest increase, albeit significant, in mouse 
hepatocyte death with the palmitate-containing conditioned me-
dium relative to control. Consistent with our earlier findings, palmi-
tate treatment alone did not appreciably affect the viability of mouse 
hepatocytes. Finally, we prepared conditioned medium from donor 
mouse hepatocytes treated with palmitate, which was applied to 
shCTRL and shCHOP HepG2 cells. There was less death of these 
human hepatocytes than when palmitate alone was applied to the 
medium (Figure 7F). These results suggest that in addition to not 
inducing NF-κB activity and secretion of target cytokines upon ex-
posure to saturated FFAs, mouse hepatocytes lack sensitivity to re-
spond to these regulatory signals.
DISCUSSION
Excess lipid accumulation is a hallmark of obesity, and lipotoxicity 
associated with saturated FFAs has been suggested to result from 
activation of the UPR observed in hepatic steatosis (Fu et al., 2012). 
Our study suggests that UPR activation plays a pivotal role in the 
pathophysiology of NASH through elevated CHOP expression 
(Figure 7G). Depletion of CHOP in human hepatocytes enhanced 
survival in response to saturated FFAs (Figure 3, A and B), and 
CHOP-dependent secretion of key cytokines, including IL-8 and 
TNFα, has central roles in macrophage recruitment and hepatocyte 
lipotoxicity (Figure 4). CHOP is suggested to facilitate secretion of 
these factors in hepatocytes exposed to saturated FFAs by enhanc-
ing phosphorylation of p65 at serine 536, triggering NF-κB entry 
into the nucleus and transcriptional expression of a collection of cy-
tokines (Figures 5, A–C, and 7G). CHOP induction of NF-κB involves 
in part signaling through IRAK2 protein (Figure 6). IRAK2 has been 
linked with phosphorylation and activation of NF-κB (Muzio et al., 
1997; Kawagoe et al., 2008; Wang et al., 2014; Zhang et al., 2014), 
and CHOP contributes to increased IRAK2 mRNA in hepatocytes 
exposed to saturated FFAs. However, palmitate treatment is sug-
gested to diminish IRAK2 mRNA translation, which, as a conse-
quence, leads to no significant change in IRAK2 protein compared 
with nonstressed conditions (Figure 6). Depletion of either IRAK2 or 
RELA blocked induction of CXCL8 (IL-8) and TNFA (TNFα) expres-
sion in response to palmitate, protecting hepatocytes against death 
and macrophage infiltration (Figures 6, D–H, and 7G). These results 
suggest that whereas IRAK2 is required for CHOP activation of NF-
κB in response to saturated FFA, increased levels of IRAK2 are not 
sufficient to induce NF-κB. Instead, other signals triggered by satu-
rated FFAs contribute in conjunction with IRAK2 to induce NF-κB 
and secreted cytokines.
Saturated FFAs are potent activators of the UPR
Saturated but not unsaturated FFAs activate UPR sensory proteins 
PERK and IRE1 before lipotoxicity (Figure 1; Ricchi et al., 2009; Fu 
et al., 2012; Berlanga et al., 2014). In fact, unsaturated FFAs can 
help prevent ER stress elicited by palmitate by supporting adaptive 
mechanisms, including activating triglyceride synthesis, which can 
conditions, the majority of IRAK2 transcripts were in the largest 
polysome fraction, fraction 7, whereas upon exposure to palmitate 
for either 6 or 12 h, there was a shift of IRAK2 mRNA toward smaller 
polysome fractions. This distribution of IRAK2 mRNA within 
polysome fractions suggests that there is lowered IRAK2 mRNA 
translation in response to eIF2α∼P and exposure to saturated FFAs, 
which provides an explanation for why IRAK2 protein was not signifi-
cantly enhanced during palmitate treatment despite there being 
increased IRAK2 mRNA. Together these results indicate that CHOP 
is required for hepatocytes to sustain elevated levels of IRAK2 
protein upon exposure to saturated FFAs. Elevated levels of IRAK2 
proteins are suggested to be required for activation of NF-κB and 
subsequent increased expression and secretion of cytokines, such 
as TNFα and IL-8, that are involved in cell death and inflammation. 
However, high levels of IRAK2 protein are not sufficient to induce 
NF-κB, suggesting that additional signals emanating from hepato-
cyte stress induced by saturated FFAs also contribute to the ob-
served activation of NF-κB.
CHOP activates NF-κB in human but not mouse 
primary hepatocytes
Rodent models of NASH are often lacking in their ability to mimic 
the human disease (Larter and Yeh, 2008; Takahashi et al., 2012). 
Earlier we showed differential affects between rodent and human 
hepatocytes with regard to lipotoxicity, suggesting a cell-autono-
mous component for the species difference (Figure 1, A–D). Next 
we determined whether there were also differences in NF-κB signal-
ing and expression of cytokines after exposure to saturated FFA. 
After 12-h treatment with palmitate, mouse primary hepatocytes 
lacked the ability to activate NF-κB, as judged by p65 phosphoryla-
tion of serine 536 (Figure 7A). There was no induction of IRAK2 
mRNA in the mouse primary hepatocytes upon palmitate exposure 
and minimal IRAK2 protein expression (Figure 7A). Although the 
UPR was activated in the mouse primary hepatocytes, as indicated 
by elevated CHOP levels, the inability of primary mouse hepato-
cytes to activate NF-κB resulted in no induction of TNFA mRNA 
(Figure 7B). Because mice do not express CXCL8, we measured 
mRNA levels for CXCL1 (KC) and CXCL2 (MIP-2), murine paralogues 
for IL-8, and found that only MIP-2 was modestly induced after pal-
mitate exposure (Figure 7B). Finally, as controls, we treated murine 
RAW cells with lipopolysaccharide (LPS) and showed that the IRAK2 
antibody effectively recognized mouse IRAK2 protein, and there 
was robust induction of both IRAK2 and TNFA mRNAs upon LPS 
treatment (Supplemental Figure S3A). These results indicate that 
although the UPR can be activated in mouse hepatocytes exposed 
to palmitate, downstream NF-κB signaling appears to be unaffected 
by saturated FFAs.
In contrast to primary mouse hepatocytes, we found that pal-
mitate treatment of primary human hepatocytes led to activation of 
NF-κB, in combination with induction of the UPR, as supported by 
increased CHOP mRNA and protein (Figure 7, C and D). Of impor-
tance, palmitate treatment of human primary hepatocytes increased 
p65 phosphorylation of serine 536 (Figure 7C) along with increases 
in IRAK2, TNFA (TNFα), and CXCL8 (IL-8) mRNAs (Figure 7D). To 
understand the functional consequence of NF-κB activation in the 
primary cells, we carried out a chemotaxis assay with both human 
KG-1 and murine RAW cells, using conditioned media from HepG2, 
human primary hepatocytes and mouse primary hepatocytes. We 
found that only HepG2 and human primary hepatocytes elicited mi-
gratory effects on the macrophage cell lines (Figure 7E). Finally, as 
noted earlier, saturated FFAs triggered death of human primary he-
patocytes but not rodent hepatocytes (Figure 1, A and B). Together 
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FIGURE 7: Human but not mouse primary hepatocytes activate NF-κB in response to palmitate. (A) Human HepG2 cells 
and mouse primary hepatocytes (MPHs) were treated with palmitate for 12 h or vehicle, and the indicated proteins were 
measured by immunoblot analyses (top). IRAK2 antibody from Abnova was used in the immunoblot analysis (see 
Supplemental Figure S3A). In parallel, IRAK2 mRNA was measured by qPCR in the HepG2 and mouse hepatocytes 
treated with palmitate for 12 h (bottom). (B) Levels of the indicated mRNAs were measured in mouse primary 
hepatocytes treated with palmitate for 12 h. (C) Human HepG2 cells and human primary hepatocytes (HPHs) were 
treated with palmitate for 12 h or vehicle, and the indicated proteins were measured by immunoblot (top). Furthermore, 
IRAK2 mRNA was measured by qPCR in the HepG2 and HPHs treated with palmitate for 12 h (bottom). (D) The indicated 
mRNA levels were measured in human primary hepatocytes treated with palmitate for 12 h. (E) Cell migration assay for 
human KG-1 and murine RAW cells using conditioned medium prepared from HepG2, HPHs, or MPHs treated with 
vehicle or palmitate for 12 h. (F) Direct treatment indicates cell death as measured by LDH release of shCTRL HepG2, 
shCHOP HepG2, or MPHs incubated with palmitate for 24 h. Alternatively, conditioned medium was prepared from 
donor shCTRL HepG2 or MPH cells that were incubated with palmitate for 24 h. The conditioned medium was then 
applied to recipient shCTRL HepG2, shCHOP HepG2, or MPHs for 24 h as indicated, and cell death was measured by 
LDH release. (G) Model for CHOP and UPR regulation of hepatocyte inflammation and death signaling during metabolic 
stress. CHOP regulation of key secreted factors, including TNFα and IL-8, occurs by signaling through NF-κB.
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CHOP activation of NF-κB is p65 phosphorylation at serine 536 by 
a signaling pathway including IRAK2. In mouse primary hepato-
cytes, there was no induction of p65 phosphorylation in response to 
palmitate, and there was minimal IRAK2 expression (Figure 7A). Fur-
thermore, expression of TNFα and murine homologue KC were not 
significantly elevated in mouse cells treated with saturated FFAs as 
observed in human hepatocytes (Figure 7B). Rodent models of 
NASH often lack the ability to mimic the human disease (Larter and 
Yeh, 2008; Takahashi et al., 2012). These results suggest that pheno-
typic deficiencies of mouse dietary models of NASH are due to the 
absence of key portions of UPR signaling through IRAK2/NF-κB, 
resulting in lowered hepatotoxicity and macrophage recruitment in 
response to saturated FFAs.
In summary, we describe new mechanisms that link chronic acti-
vation of the UPR with cell death and inflammation, two critical com-
ponents of progression from hepatic steatosis to NASH. Although it 
is well known that liver-related complications due to NASH are on 
the rise, there are no Food and Drug Administration–approved ther-
apeutic interventions to control progression of simple steatosis to 
NASH. Furthermore, there is a need for improved prognostic bio-
markers and an understanding of genetic susceptibility to NASH. It 
is noteworthy that there are genetic polymorphisms in IRAK2 that 
significantly alter NF-κB activation (Muzio et al., 1997; Kawagoe 
et al., 2008; Wang et al., 2014; Zhang et al., 2014), and our study 
suggests that these genetic alterations will alter CHOP signaling in 
response to saturated FFAs and affect induction of secreted factors 
in hepatocytes that trigger inflammation and death. UPR signaling 
events will also offer new strategies for the diagnosis and treatment 
of NASH.
MATERIALS AND METHODS
Cell culture and measurements of cell viability
HepG2 cells were purchased from the American Type Culture 
Collection and cultured in MEM (Life Technologies, Grand Island, 
NY) supplemented with 1 mM nonessential amino acids, 1 mM 
sodium pyruvate, 2 mM GlutaMAX, and 10% (vol/vol) fetal bovine 
serum at 37°C. Cells were seeded at 15,000 cells per 96-well plate 
or 3.7 × 106 cells per 10-cm dish and treated with FFAs in 1% 
bovine serum albumin (BSA) for the indicated times. Palmitate, 
stearate, and oleate were reconstituted first using warm isopropa-
nol at 80 mM and then diluted to desired concentrations using 
medium containing 10% fetal bovine serum and 1% BSA. After 
cell treatment with FFA for the indicated times, medium was col-
lected from cells and LDH determined (Chen et al., 1990). Data 
were normalized to total LDH release by 10% Triton X-100. Condi-
tioned medium was collected and subjected to centrifugation at 
200 × g for 10 min before addition of recipient cells. Comparison 
of LDH activity in the donor conditioned medium before and after 
recipient cell incubation for 12 or 24 h indicated that there was 
minimal contribution of LDH activity carried over from the condi-
tioned medium. Furthermore, independent measurements of cell 
death by imaging with calcein-AM supported key findings using 
LDH release. For inactivation studies, conditioned medium super-
natants were treated at 1 h using heat inactivation at 56°C, 
10 μg/ml RNase A at 37°C, or 50 μg/ml Proteinase K at 37°C 
(Jandu et al., 2006; Mahadevan et al., 2011). Recombinant TNFα 
(PHC03015L; Life Technologies) and IL-8 (PHC0884, Life Technol-
ogies) prepared in phosphate-buffered saline (PBS) solution with 
BSA were applied to shCHOP cell culture medium at 10 or 
1000 ng/ml, respectively, with or without 600 μM palmitate, as 
indicated. Cells were incubated for 24 h, and cell viability was 
measured by LDH release.
contribute to growth of lipid droplets. There are many models for 
how saturated FFAs can trigger ER stress (Fu et al., 2012). We found 
that a portion of palmitate is colocalized to the ER (Figure 2, A–C) 
and that saturated FFAs can alter the distribution of the lipid 
droplets (Figures 1E and 2A), which is predominantly synthesized at 
the ER (Sturley and Hussain, 2012). These findings suggest that 
saturated FFAs modify the ER membrane and stress this organelle 
(Ariyama et al., 2010), an idea consistent with a recent study that 
showed that PERK and IRE1 mutants that lacked their ER luminal 
sensing domains retained their ability to respond to increased lipid 
saturation (Volmer et al., 2013). It was proposed that these UPR sen-
sors directly monitor the lipid composition of the ER membrane. It 
is curious that expression of the UPR sensor ATF6 was not activated 
in HepG2 cells in response to palmitate (Supplemental Figure S1B; 
Kitai et al., 2013). The apparent lack of ATF6 induction may be a 
consequence of palmitate alteration of vesicular trafficking required 
for ATF6 passage to the Golgi for cleavage and release to the 
nucleus.
CHOP induces secretion of cytokines involved in hepatocyte 
death and inflammation
Inflammation plays a critical role in a variety of liver pathologies, 
and activation of chronic inflammation may be an important tip-
ping point in the progression from simple hepatic steatosis to 
NASH (Malhi and Kaufman, 2011; Brenner et al., 2013). Secretion 
of inflammatory cytokines by resident or invading immune cells and 
release of proinflammatory and chemotactic alarmins from stressed 
and dying hepatocytes are suggested to be central to progressive 
inflammation in liver pathology. We propose a novel mechanism by 
which chronically stressed hepatocytes produce cytokines that are 
part of the cell death and proinflammatory responses (Figure 7G). 
Elevated and sustained CHOP expression is considered to be a 
potent trigger for the UPR to switch from an adaptive function to 
death response (Marciniak and Ron, 2006; Tabas and Ron, 2011). 
This study suggests that the signaling pathway by which CHOP 
activates NF-κB involves enhanced phosphorylation of p65, which 
facilitates nuclear localization and transcriptional activation of NF-
κB (Figures 5, A and B, and 7G; Sasaki et al., 2005). Whereas knock-
down of CHOP substantially reduced phosphorylation of NF-κB, 
loss of CHOP function did not deter lowered IκBα levels during 
treatment with palmitate. Translational expression of IκBα is sub-
stantially reduced upon PERK phosphorylation of eIF2α∼P (Wek 
et al., 2006); therefore, there are multiple sites for UPR regulation 
of NF-κB. It is noteworthy that knockdown of RELA (p65) did not 
diminish enhanced CHOP expression by palmitate (Figure 5J), 
which supports the idea that CHOP functions upstream of NF-κB to 
induce expression of cytokines. It was reported that both CHOP 
and NF-κB can bind to the CXCL8 (IL-8) gene promoter in stressed 
human bronchial epithelial cells, suggesting that CHOP may also 
contribute directly to transcriptional activation of cytokine gene ex-
pression (Bezzerri et al., 2011).
UPR in NASH and model systems
Studies using rodent dietary models of NASH and inflammation 
suggest distinct differences from humans (Larter and Yeh, 2008; 
Takahashi et al., 2012). Our results suggest a cell-autonomous com-
ponent of this species difference that is a property of the hepatocyte 
(Figure 7G). Whereas both human and mouse hepatocytes showed 
induction of the UPR and CHOP expression in response to saturated 
FFAs, only human liver cells showed activation of NF-κB and in-
creased expression of key cytokines, such as TNFα, which triggered 
cell death and inflammation. An underlying contributor to human 
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fixed in modified Karnovsky’s fixative, embedded in agar, postfixed 
with 1% osmium tetroxide, dehydrated through an ascending series 
of ethanol, and processed and embedded in epoxy resin. Toluidine 
blue–stained sections of ∼1-μm thickness were collected on glass 
slides and prepared for ultrathin area selection. Ultrathin sections 
were collected on 200-mesh copper grids, counterstained with ura-
nyl acetate and Sato’s lead stain, and examined in a CM100 Philips 
transmission electron microscope. Digital images of representative 
tissue areas were captured for evaluation.
Isolation of primary hepatocytes
C57BL/6 female mouse and Sprague–Dawley male rat primary 
hepatocytes were isolated by anesthetizing rodents with sodium 
pentobarbital and perfusing the liver through the portal vein for 
12–14 min with Perfusion Buffer (Life Technologies), followed by 
10 min of L15 Buffer (Corning, Corning, NY) containing collagenase 
and trypsin inhibitor (Worthington, Lakewood, NJ) at 42°C. After 
digestion, livers were extracted from animals; digested cells were 
scraped and shaken from liver, followed by filtration and two spins 
at 50 × g for 4.5 min as described (Berry and Friend, 1969; Seglen, 
1972). Primary human hepatocytes were purchased from Life Tech-
nologies (lots Hu8203, Hu1743, and Hu1745).
Polysome profiling
HepG2 cells were cultured in the presence of vehicle or 600 μM 
palmitate for 6 or 12 h, as indicated. At 10 min before harvesting the 
cells, 50 μg/ml cyclohexamide was added to the cultures for 10 min. 
Cells were then washed with ice-cold PBS containing 50 μg/ml cy-
clohexamide and lysed, and lysates were added to 10–50% sucrose 
gradient, subjected to centrifugation in a Beckman SW41Ti rotor for 
2 h at 4°C at 40,000 rpm, and monitored by absorbance at 254 nm 
as described (Teske et al., 2011). ATF4, CHOP, and IRAK2 mRNA 
levels were measured in each of seven sucrose gradient fractions as 
described (Baird et al., 2014). Amounts of transcripts in each fraction 
are presented as the percentage of the total for the indicated 
mRNA. The percentage change in association with large polysomes 
(fractions 5–7) in response to palmitate treatment was measured for 
each of the three transcripts.
Measurements of mRNA by qPCR and luciferase activities
RNA was isolated from cells using TRIzol reagent (Invitrogen/Life 
Technologies), and cDNA synthesis was carried out using TaqMan 
RT kit (Applied Biosystems/Life Technologies) according to manu-
facturer’s instructions. Primers used in the study are listed in Supple-
mental Table S1. Transcript measurements were normalized to 
GAPDH for HepG2 and human primary hepatocytes or ACTB (β-
actin) for mouse primary hepatocytes. HepG2 cells were transiently 
transfected using FuGENE 6 with the NF-κB reporter plasmid 
p5XIP10κB (Lu et al., 2004) and Renilla luciferase reporter plasmid 
for 24 h, and the transfected cells were treated with palmitate or 
vehicle 12 h, as indicated. Luciferase assays were carried out using 
the Dual-Luciferase reporter assay system (Promega, Madison, WI) 
following the manufacturer’s instructions.
Cell migration assay
Cell migration assays were carried out using transwell Boyden 
chambers with 5-μm pores from Cell BioLabs (San Diego, CA; CBA-
105). Macrophage murine RAW 264.7 and human KG-1 cells were 
plated at 50,000 cells/insert in serum-free DMEM. Conditioned me-
dium from control or knockdown cells was added to the lower wells, 
and cells were allowed to migrate for 6 h at 37°C. Alternatively, 
conditioned medium was prepared from shCHOP cells cultured for 
Stable gene knockdowns
Stable knockdown and control cells were generated by transduc-
ing HepG2 cells with lentivirus carrying shRNA from Sigma-
Aldrich (St. Louis, MO) against shCHOP (TRCN0000364393 
and TRCN0000007263), shATF4 (TRCN0000013574 
and TRCN0000013575), shCXCL8 (IL-8) (TRCN0000058029 and 
TRCN0000058030), shTNFA (TNFα) (TRCN0000355911 and 
TRCN0000003757), shRELA (p65)(TRCN0000014687), shIRAK2 
(TRCN0000431467 and TRCN0000418461), or control (SCH001). 
Cells taking up viral particles were selected for by resistance to 
10 μg/ml puromycin and maintained for at least 1 wk in the absence 
of puromycin before experiments were conducted. PERK-KO cells 
were constructed by using a plasmid from Sigma-Aldrich 
(HS0000302974) expressing the guide RNA targeting sequence 
CGGCAAGGACGGUGGCCGCGGG.
Immunoblot analysis and ELISAs
Protein lysates were collected, quantified using Pierce BCA Protein 
Assay Kit (Thermo Scientific, Waltham, MA), and separated by SDS–
PAGE using 4–12% Bis-Tris gels. After electrophoresis, proteins 
were transferred to nitrocellulose filters and blocked for 1 h at room 
temperature with BLOTTO (Pierce). Filters were incubated over-
night with the following antibodies: from Cell Signaling Technology 
(Beverly, MA), eIF2α∼P (9721), eIF2α (5324), ATF4 (11815S), GAPDH 
(2118S), TNFα (6945), IκBα (4812), p65 (8242), p65∼P (3033), IRAK1 
(4504), IRAK2 (4367), IRAKM (4369), and IRAK4 (4363); from Santa 
Cruz Biotechnology (Dallas, TX), CHOP (sc-7351); from Sigma-
Aldrich, β-actin (A5441); from Novus, IL-8 (H00003576-M05); and 
from Abnova (Littleton, CO), IRAK2 (H00003656-M04). Total PERK 
was measured by using antibody (5683) from Cell Signaling Technol-
ogy. Because lysates were separated by electrophoresis by using 
4–12% gradient gels before the PERK immunoblot analysis, there 
was no visible shift in the migration of PERK protein as a conse-
quence of phosphorylation and activation. Phosphorylation of PERK 
was measured by using rabbit polyclonal antibody prepared against 
a synthesized PERK polypeptide that was phosphorylated at Thr-
890. A 45-biomarker Multi-Analyte Profile Human Inflammation-
MAP, version 1.0, from Myriad RBM (Austin, TX) was used to mea-
sure cytokines, chemokines, and acute-phase reactants, in 
conditioned medium from HepG2 cells treated with palmitate, ole-
ate, or vehicle for 12 h. Conditioned medium was collected and 
subjected to centrifugation at 200 × g for 10 min. The fold change 
for the indicated cytokine in response to either FFA was normalized 
to vehicle. Human IL-8 and TNFα in the conditioned media were 
measured by using R&D Systems (Minneapolis, MN) Quantikine 
ELISA kits D8000C and DTA00C, respectively.
Cell imaging
For neutral lipid accumulation, cells were fixed with 1× Prefer 
(Anatech) and then stained with 1× LipidTox Deep Red Neutral Lipid 
Stain and 10 μg/ml Hoechst 33342, both from Life Technologies. 
For immunofluorescence, cells were fixed and permeabilized with 
0.1% Triton X-100 for 10 min, followed by overnight incubations 
with primary antibody and corresponding secondary Alexa Fluor 
conjugates. For CLICK-IT reactions, 5 μM Alexa Fluor 488 alkyne 
was used (Life Technologies). To monitor viability, live cells were 
stained with 2.5 μM calcein-AM and 10 μg/ml Hoechst for 30 min 
before imaging. All images were acquired via spinning disk confocal 
microscopy using Opera (PerkinElmer, Waltham, MA) and quantified 
using Columbus. Three-dimensional rendering of z-stack images 
was performed and quantified using Volocity (PerkinElmer). For 
electron microscopy, cells were concentrated by centrifugation, 
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12 h with either vehicle or 600 μM palmitate, and then 10 ng/ml 
recombinant TNFα and 1000 ng/ml of IL-8 was added to this me-
dium just before performing the KG-1 cell migration assay.
Statistical analysis
Data are depicted as mean ± SD. Differences between multiple 
groups were analyzed using a one-way analysis of variance followed 
by a post hoc Tukey honest significant difference test to compare 
multiple groups. p < 0.05 was considered statistically significant and 
is indicated by an asterisk, and treatment groups considered statis-
tically significant from shCTRL treatment are indicated by the num-
ber sign (#) unless otherwise noted.
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